Increased Cash NOI and AFFO
Reported cash NOI of $40.8 million, an increase from $39.9 million in Q2 2024, and an AFFO of $31.7 million, up from $30.8 million in the previous quarter.
Strategic Acquisitions and Developments
Acquired an inpatient rehabilitation facility for $28.4 million and closed on two mezzanine loans for future developments, expanding the portfolio with over $181 million in acquisitions and development loans.
Strong Portfolio and Lease Renewals
Achieved a 97% renewal rate on approximately 134,000 square feet and maintained a weighted average remaining lease term of 8.3 years.
Robust Financial Position
Maintained a conservative leverage ratio of 3.5 times EBITDAre and had cash, cash equivalents, and availability of approximately $528.6 million.